Stockreport

How Investors May Respond To Rapport Therapeutics (RAPP) Licensing RAP-219 To Tenacia In Greater China [Yahoo! Finance]

Rapport Therapeutics, Inc.  (RAPP) 
PDF bipolar candidate RAP-219 across Greater China, in a deal including a US$20 million upfront payment and up to approximately US$308 million in potential milestones plus t [Read more]